SPL 1.72% $1.15 starpharma holdings limited

Starpharma in a nutshell

  1. 7,374 Posts.
    lightbulb Created with Sketch. 233
    End of December quarter just under 40 million in the bank

    Vivagel coated condoms in 3 jurisdictions - Australia, New Zealand and Japan

    Estimated royalties given by analysts range from US$200,000 FY 15 to US$21 million by 2021

    Phase 111 R-BV trials are currently being conducted in 48 sites and eventually 100 locations across USA, Mexico, Europe and Asia

    Systematic Relief for Bacterial Vaginosis documentation is being submitted for registration in non US jurisdictions

    Dep-Docetaxel Phase 1 clinical trial being conducted in Australia in 3 locations are progressing nicely and researchers are currently testing for the MTD. So far results are extremely promising. I am sure we will see updated information of these tests by end of month

    we are coming to the end of this long tunnel. Just a few short months to go - and people will understand why I am so passionate about Starpharma

    The above comments have been taken from various sources and should not be construed as investment advice
    Last edited by antibotter: 13/02/15
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
(20min delay)
Mkt cap $432.9M
Open High Low Value Volume
$1.16 $1.17 $1.12 $311.4K 270.7K

Buyers (Bids)

No. Vol. Price($)
2 3478 $1.14

Sellers (Offers)

Price($) Vol. No.
$1.15 8102 2
Last update - 16.10pm 21/01/2019 (20 minute delay) ?
-0.02 ( 1.45 %)
Open High   Low Volume
$1.15 $1.17   $1.13 28367
Last updated 15.59pm 21/01/2019 (live) ?
SPL (ASX) Chart
GET SUPPORT arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.